Hydroxyethyl starch (HES) 130/0.4 was a novel preparation, developed to improve the pharmacokinetics of current medium molecular weight HES solutions.
A pancreatic enzyme preparation developed particularly for infants, Creon® for children (CfC), contains smaller granules to be administered with a dosing spoon (5000 lipase units per scoop).
KLMB and SA performed sample preparation, developed protocols, participated in MS data analysis, and drafted the manuscript.
This is the first evidence in the literature that a complex MVT preparation developed for human consumption significantly delayed progression of diabetes in an animal model.
The standard third instar larval body-wall muscle preparation developed by Jan and Jan 19766) was used for electrophysiological recordings (Zhang et al., 1998; Bao et al., 2005).
The ICP-MS-DRC method for metals in plasma was developed according to published procedures (Pruszkowski et al. 1998), with modifications for plasma sample preparation developed in our laboratory (Chen et al. 2007).
This preparation develops large pressor responses to airways hypoxia, but only if the lungs are first prestimulated, or primed, with a vasoactive substance that raises the basal perfusion pressure and overall vasoreactivity (16, 18, 33).
This chapter describes two preparations developed in the laboratories that in large part replicate the complexity of the embryonic milieu and the numerous factors that affect cell interactions and guidance, and that nonetheless offer the pliability and visibility of tissue culture.
Although most vitamin D preparations developed thus far have focused on side-chain modifications, providing many useful analogues with high potency and selectivity, in recent years, modifications of the A-ring has attracted much attention because it can afford useful analogues exhibiting unique activity profiles as well.
